Business & Consumer Services » Business Services | Medifron DBT Co. Ltd.

Medifron DBT Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
2,015,058.70
8,502,441.80
1,707,931.10
3,961,205.60
11,451,807.50
Depreciation, Depletion & Amortization
127,327.90
150,169.20
33,790.70
18,274.20
15,606.70
Other Funds
1,044,652.80
6,212,161.50
1,864,361.50
3,782,863.50
12,194,329.00
Funds from Operations
843,077.90
2,140,111.00
190,221.10
160,067.90
758,128.20
Changes in Working Capital
667,666.70
2,140,813.00
360,486.90
991,820.20
1,928,413.50
Net Operating Cash Flow
1,510,744.60
702.00
170,265.80
1,151,888.20
1,170,285.20
Capital Expenditures
37,568.10
13,531.30
33,888.40
46,116.30
57,165.90
Sale of Fixed Assets & Businesses
-
-
-
-
7,545.50
Purchase/Sale of Investments
1,400,000.00
260,177.60
4,750,569.60
1,552,913.00
7,537,542.50
Net Investing Cash Flow
390,413.70
273,708.90
4,784,458.00
1,595,665.00
8,292,163.00
Issuance/Reduction of Debt, Net
-
-
5,978,763.80
-
-
Net Financing Cash Flow
-
-
5,978,763.80
-
10,796,156.20
Net Change in Cash
1,120,330.90
273,007.00
1,024,039.90
443,776.80
1,333,708.00
Free Cash Flow
1,516,094.60
702.00
197,175.80
1,178,251.80
1,170,285.20
Other Sources
27,108.00
-
-
93,868.20
200,000.00
Change in Capital Stock
-
-
-
-
10,796,156.20
Other Uses
999,126.10
-
-
5,000.00
905,000.00

About Medifron DBT Co.

View Profile
Address
1401 Woolim Blue 9 Business Center A
Seoul SL 07547
Korea, Republic Of
Employees -
Website http://www.medifron.com
Updated 09/14/2018
Medifron DBT Co., Ltd. engages in the provision of information technology (IT) content services. It operates through the IT and New Medicine business divisions. The IT business division offers interactive voice response system which provides consultation, voicemail, automatic guidance, video conferencing, predictive dialing, audiotext, voice processing function, help desk function, collaborative computing, call switching, and call control.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.